SLC2A4 and type 2 diabetes mellitus: Evidence showed that isoflavone improved the endothelial function, lowered blood pressure and blood glucose, and had beneficial effects on decreasing the cardiovascular risk of patients with T2D by affecting AMPK phosphorylation and glucose transporter 4 (GLUT4) in vitro and in preclinical and clinical studies [62,63,64].